Jindal Steel in talks to get Covid-19 vaccines for its employees

The Indian government kicked off one of the world's largest vaccination campaigns over the weekend

vaccine
Representational image
Reuters BENGALURU
2 min read Last Updated : Jan 18 2021 | 5:41 PM IST

Steel producer Jindal Steel and Power Ltd said on Monday it was reaching out to COVID-19 vaccine manufacturers for a bulk supply of doses for its employees after the Indian government kicked off one of the world's largest vaccination campaigns over the weekend.

"Will try to get these doses after completion of all frontline COVID warriors' vaccination," Pankaj Lochan, chief human resource officer, JSPL, said in a statement, making it among the first big companies to make a public statement on vaccination plans.

Another steel producer, Tata Steel Ltd said the company would vaccinate its employees as per the government guidelines when vaccines were made available.

India began vaccinating health workers and other frontline workers, such as those in sanitation and security, followed by about 270 million people older than 50 or deemed high-risk because of pre-existing medical conditions.

India is currently using Britain's Oxford University/AstraZeneca vaccine, which is also being produced in India, and a government-backed vaccine developed by India's Bharat Biotech.

"We have also categorised employees in order of vulnerability, so the ones above the age of 50 years and those who were infected from COVID-19 can be vaccinated first," Lochan said.

JSPL, however, did not provide details on vaccine manufacturers that the company was getting in touch with or the number of doses it was looking for.

 

(Reporting by Nallur Sethuraman in Bengaluru; Editing by Shailesh Kuber)

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :CoronavirusCoronavirus VaccineCoronavirus Tests

First Published: Jan 18 2021 | 5:35 PM IST

Next Story